Ligand validation:3LG1

PG6: 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3LG1_PG6_A_532	42%	49%	0.143	0.872	0.83	1.13	-	2	0	0	94%	0.8889
3LG1_PG6_A_539	40%	78%	0.123	0.944	0.26	0.62	-	-	0	0	39%	0.3889
3LG1_PG6_A_534	34%	80%	0.121	0.905	0.59	0.27	-	-	0	0	44%	0.4444
3LG1_PG6_A_544	30%	90%	0.141	0.946	0.34	0.26	-	-	1	0	22%	11.110000000000001
3LG1_PG6_B_531	20%	48%	0.165	0.775	0.9	1.09	-	1	1	0	94%	0.9444
3LG1_PG6_B_542	13%	82%	0.211	0.828	0.45	0.35	-	-	0	0	56%	0.2778
3LG1_PG6_B_541	9%	75%	0.265	0.798	0.61	0.39	-	-	0	0	78%	0.7778
3LG1_PG6_A_542	9%	82%	0.24	0.744	0.53	0.27	-	-	0	0	89%	0.4444
3LG1_PG6_B_539	6%	75%	0.214	0.752	0.57	0.42	-	-	1	0	44%	0.4444
3LG1_PG6_A_543	2%	82%	0.295	0.668	0.51	0.3	-	-	0	0	56%	0.2778
3LG1_PG6_B_534	2%	79%	0.421	0.793	0.44	0.43	-	-	1	0	56%	0.2778
3OWM_PG6_A_529	19%	70%	0.153	0.866	0.62	0.55	-	-	0	0	33%	0.3333
3JR7_PG6_A_299	67%	21%	0.093	0.899	1.78	1.57	5	3	3	0	100%	1
5UL5_PG6_B_604	59%	73%	0.11	0.942	0.49	0.56	-	-	0	0	72%	0.7222
7YUG_PG6_A_401	55%	68%	0.149	0.918	0.41	0.8	-	1	1	0	100%	1
4F7F_PG6_A_202	49%	57%	0.118	0.875	0.59	1.04	-	1	0	0	94%	0.9444
7NB4_PG6_A_403	49%	95%	0.19	0.938	0.23	0.17	-	-	1	0	100%	0.5

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.